These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7622857)
1. Predictors for hypertensive nephropathy: results of a 6-year follow-up study in essential hypertension. Schmieder RE; Veelken R; Gatzka CD; Rüddel H; Schächinger H J Hypertens; 1995 Mar; 13(3):357-65. PubMed ID: 7622857 [TBL] [Abstract][Full Text] [Related]
2. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin. Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859 [TBL] [Abstract][Full Text] [Related]
3. Beta-2-microglobulin is superior to N-acetyl-beta-glucosaminidase in predicting prognosis in idiopathic membranous nephropathy. Hofstra JM; Deegens JK; Willems HL; Wetzels JF Nephrol Dial Transplant; 2008 Aug; 23(8):2546-51. PubMed ID: 18308774 [TBL] [Abstract][Full Text] [Related]
4. Long-term renal function in primary hypertension. An epidemiological and pathophysiological study. Siewert-Delle A Scand J Urol Nephrol Suppl; 1999; 199():1-36. PubMed ID: 10349677 [TBL] [Abstract][Full Text] [Related]
5. Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up. Kanno Y; Okada H; Saruta T; Suzuki H Clin Nephrol; 2000 Nov; 54(5):360-5. PubMed ID: 11105796 [TBL] [Abstract][Full Text] [Related]
6. Renal outcome 25 years after donor nephrectomy. Goldfarb DA; Matin SF; Braun WE; Schreiber MJ; Mastroianni B; Papajcik D; Rolin HA; Flechner S; Goormastic M; Novick AC J Urol; 2001 Dec; 166(6):2043-7. PubMed ID: 11696703 [TBL] [Abstract][Full Text] [Related]
7. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics. Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430 [TBL] [Abstract][Full Text] [Related]
8. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function. Moriyama T; Honda K; Nitta K; Yumura W; Nihei H Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901 [TBL] [Abstract][Full Text] [Related]
9. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications. Agarwal R Am J Nephrol; 2007; 27(1):92-100. PubMed ID: 17284896 [TBL] [Abstract][Full Text] [Related]
10. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Estacio RO; Jeffers BW; Gifford N; Schrier RW Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192 [TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of beta2-microglobulin and IgG predict prognosis in idiopathic membranous nephropathy: a validation study. Branten AJ; du Buf-Vereijken PW; Klasen IS; Bosch FH; Feith GW; Hollander DA; Wetzels JF J Am Soc Nephrol; 2005 Jan; 16(1):169-74. PubMed ID: 15563570 [TBL] [Abstract][Full Text] [Related]
12. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy. Peters HP; van den Brand JA; Wetzels JF Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847 [TBL] [Abstract][Full Text] [Related]
13. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy. Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739 [TBL] [Abstract][Full Text] [Related]
14. Long-term renal function preservation after renal artery stenting in patients with progressive ischemic nephropathy. Rocha-Singh KJ; Ahuja RK; Sung CH; Rutherford J Catheter Cardiovasc Interv; 2002 Oct; 57(2):135-41. PubMed ID: 12357507 [TBL] [Abstract][Full Text] [Related]
15. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study. Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z; Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787 [TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin converting enzyme inhibitor on renal function in patients of membranoproliferative glomerulonephritis with mild to moderate renal insufficiency. Giri S; Mahajan SK; Sen R; Sharma A J Assoc Physicians India; 2002 Oct; 50():1245-9. PubMed ID: 12568207 [TBL] [Abstract][Full Text] [Related]
17. Determinants of urinary albumin excretion reduction in essential hypertension: A long-term follow-up study. Pascual JM; Rodilla E; Miralles A; Gonzalez C; Redon J J Hypertens; 2006 Nov; 24(11):2277-84. PubMed ID: 17053551 [TBL] [Abstract][Full Text] [Related]
18. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy. Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931 [TBL] [Abstract][Full Text] [Related]
19. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy. Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375 [TBL] [Abstract][Full Text] [Related]
20. Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy. Alderman MH; Melcher L; Drayer DE; Reidenberg MM N Engl J Med; 1983 Nov; 309(20):1213-7. PubMed ID: 6633570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]